Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy

被引:0
|
作者
ZHANG Bo LIU Zhihong ZENG Caihong ZHENG Jingmin CHEN Huiping ZHOU Hong and LI LeishiResearch Institute of Nephrology Jingling Hospital Nanjing University School of Medicine Nanjing ChinaDepartment of Nephrology First Affiliated Hospital of Nanjing Medical University Nanjing China [210002 ,210029 ]
机构
关键词
D O I
暂无
中图分类号
R692 [肾疾病];
学科分类号
摘要
Background Lipoprotein glomerulopathy (LPG) is a renal disease characterized by thrombus-like lipoproteins in the glomerular capillaries and its abnormal lipoprotein profiles with marked elevation of apolipoprotein E (apoE). In this study, 15 Chinese patients with LPG were involed in exploring the association of the genetic variation and its plasma level in the pathogenesis of LPG.Methods A retrospective analysis of the clinical and pathological features was made in 15 patients with LPG. Plasma concentrations of apoE were measured with radial immunodiffusion assay. Genetic variations of apoE gene were detected using polymerase chain reaction and restriction fragment length polymorphism. Glomerular deposition of apoA, apoB and apoE in these patients were detected by immunofluorescence staining using monoclonal antibodies. Results Biochemical profiles of lipids and lipoproteins revealed markedly elevated levels of triglyceride, apoB and apoE, but approximately normal levels of total cholesterol, apoA1 and lipoprotein(a) [Lp(a)], which resembled familial hypertriglyceridemia. Genetic analysis demonstrated that the genotype distribution of apoE were 7 cases with (ε3/ε 4,)4 cases with ε3/ε 3 and 2 cases with ε2/ε 3. The other 2 cases (a mother and her son) showed a same distinct band. The band pattern of later 2 cases was quite similar to the apoE variant of Tokyo type. The calculated allele frequency of ε 4 was relatively high in cases with LPG in comparison with that in the normal controls. We further divided the 13 patients into three groups according to their genotypes of apoE. Patients with the genotype of apoE ε2/ε3 showed a lower level of plasma apoE as compared to those with apoE ε3/ε4 (P<0.05). The serum level of high-density lipoprotein (HDL) was the lowest in patients with the genotype of apoE ε3/ε4. No difference was found among the patients with different apoE genotype in the other clinical and pathological characteristics. Conclusions The genotype of apoE ε3/ε4 is the predominant one in Chinese patients with LPG. Patients with this genotype tend to have a higher plasma level of apoE and more severe lipid dysmetabolism. No correlation was found between the genotype of apoE and the clinical features in patients with LPG.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 50 条
  • [41] Apolipoprotein E Sendai (145 arginine->proline): A new variant with lipoprotein glomerulopathy.
    Oikawa, S
    Matsunaga, A
    Saito, T
    Sato, H
    Hoshi, K
    Abe, K
    Kudo, K
    Toyota, T
    Sasaki, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1852 - A1852
  • [42] A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy
    Bomback, Andrew S.
    Song, Huijuan
    D'Agati, Vivette D.
    Cohen, Scott D.
    Neal, Alison
    Appel, Gerald B.
    Rovin, Brad H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (10) : 3442 - 3446
  • [43] Apolipoprotein E Mutation and Double Filtration Plasmapheresis Therapy on a New Chinese Patient with Lipoprotein Glomerulopathy
    Li, Wencheng
    Wang, Yang
    Han, Zhiwu
    Luo, Changqing
    Zhang, Chun
    Xiong, Jing
    KIDNEY & BLOOD PRESSURE RESEARCH, 2014, 39 (04): : 330 - 339
  • [44] EFFECTS OF APOLIPOPROTEIN-E POLYMORPHISM ON PLASMA LIPOPROTEIN(A) LEVELS
    HORITA, K
    ETO, M
    SAITO, M
    NAKATA, H
    IWASHIMA, Y
    ITO, H
    TAKAHASHI, M
    KONDO, A
    MORIKAWA, A
    MAKINO, I
    ARTERY, 1993, 20 (06) : 324 - 336
  • [45] GENETIC-HETEROGENEITY OF APOLIPOPROTEIN-E AND ITS INFLUENCE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS
    DEKNIJFF, P
    VANDENMAAGDENBERG, AMJM
    FRANTS, RR
    HAVEKES, LM
    HUMAN MUTATION, 1994, 4 (03) : 178 - 194
  • [46] GENETIC-VARIATION IN HUMAN APOLIPOPROTEIN-E
    WARDELL, MR
    SUCKLING, PA
    JANUS, ED
    JOURNAL OF LIPID RESEARCH, 1982, 23 (08) : 1174 - 1182
  • [47] Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations
    Yang, Mingxin
    Weng, Qinjie
    Pan, Xiaoxia
    Hussain, Hafiz Muhammad Jafar
    Yu, Shuwen
    Xu, Jing
    Yu, Xialian
    Liu, Yunzi
    Jin, Yuanmeng
    Zhang, Chunli
    Li, Xiao
    Ren, Hong
    Chen, Nan
    Xie, Jingyuan
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (08):
  • [48] Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy
    Konishi, K
    Saruta, T
    Kuramochi, S
    Oikawa, S
    Saito, T
    Han, H
    Matsunaga, A
    Sasaki, J
    NEPHRON, 1999, 83 (03): : 214 - 218
  • [49] Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese
    Wang, Bin
    Zhao, Hongye
    Zhou, Li
    Dai, Xiaoxia
    Wang, Dayu
    Cao, Jun
    Niu, Wenquan
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 276 (1-2) : 118 - 122
  • [50] Lipoprotein glomerulopathy associated with psoriasis vulgaris: Report of 2 cases with apolipoprotein E3/3
    Chang, CF
    Lin, CC
    Chen, JY
    Yang, AH
    Shiao, MS
    Kao, JT
    Yang, WC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03)